Influenza

Get Email Updates

Influenza Guide

Alison Beaver Guide

Have a question? We're here to help. Ask the Community.

ASK

Free Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER!

Drug Developed at MIT Could be Answer to Viral Infections

By Deborah Ross HERWriter August 15, 2011 - 12:42pm
 
Rate This
0 comments View Comments

It’s scientific jargon at its best. A drug called DRACO binds to double-stranded RNA to initiate apoptosis, or cell suicide. But it’s all good, especially in the labs of the Massachusetts Institute of Technology in Boston, where scientists have revealed DRACO as a breakthrough drug with the potential to fight any viral infection.

That means that with further testing and product development, DRACO might eventually go to work against the common cold, stomach flu, influenza and a host of other conditions fueled by a variety of viruses.

As explained in the August 11, 2011, online edition of Time magazine, DRACO is a broad-spectrum treatment that zeroes in on any virally infected cells and triggers cell suicide while leaving healthy cells alone. “In theory, it should work against all viruses,” said Todd Rider of MIT Lincoln Laboratory’s Chemical, Biological, and Nanoscale Technologies Group, the scientists behind the new technology.

DRACO stands for Double-stranded RNA Activated Caspase Oligomerizers. In simple terms, double-stranded RNA is what happens when a virus takes over a healthy cell and starts replicating. But our bodies naturally produce proteins to attach to double-stranded RNA to fight viral infections. In developing DRACO, the MIT scientists combined these proteins with yet other proteins that induce cell suicide. And it worked on lab mice, wiping out an infection of the H1N1 flu virus.

According to Time magazine, DRACO was effective against 15 different viruses in lab tests using animal and human cells.

Still needed are additional lab trials with infected mice. Then DRACO could move on to trials involving larger animals and eventually humans.

The long-term implications are pretty amazing, if DRACO testing moves forward: possible cures for not only the common cold and flu, but also dengue fever, severe acute respiratory syndrome (SARS) and polio. Someone commenting online at the MIT site announcing the breakthrough said DRACO could be as big as the 20th century discovery of penicillin to fight bacterial infections.

 
Rate This
0 comments View Comments

We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.

Around the Web

Tags

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
By hitting submit, you agree to EmpowHER's terms of service and privacy policy

Improved

620 Health

Changed

294 Lives

Saved

211 Lives
1 lives impacted in the last 24 hrs Learn More

Take our Featured Poll

How likely are you to trust an online community or social network when it comes to your health and wellness?:
View Results